Table 3

Macular pigment optical density (MPOD) response to placebo. See Table 2 for details.
Subject/eye
 MPOD pre AU
 SD pre AU
 Rate of change in MPOD ± SE, mAU/day
 p
 Significance of rate of change
11/L
 0.244
 0.034
 0.01 ± 0.43
 0.99
 No signif. change
11/R
 0.246
 0.055
 -0.20 ± 0.26
 0.46
 No signif. change
12/L
 0.570
 0.043
 -0.99 ± 0.23
 0.0001
 Signif. decrease
12/R
 0.551
 0.105
 -0.10 ± 0.22
 0.65
 No signif. change
13/L
 0.473
 0.065
 0.00 ± 0.30
 0.99
 No signif. change
13/R
 0.397
 0.077
 0.66 ± 0.41
 0.12
 No signif. change
14/L
 0.825
 0.067
 0.03 ± 0.94
 0.98
 No signif. change
14/R
 0.922
 0.186
 0.36 ± 0.33
 0.30
 No signif. change
15/L
 0.328
 0.050
 0.14 ± 0.22
 0.53
 No signif. change
15/R
 0.334
 0.058
 -0.11 ± 0.24
 0.66
 No signif. change
16/L
 0.492
 0.048
 -0.72 ± 0.16
 <0.0001
 Signif. decrease
16/R
 0.527
 0.022
 -0.60 ± 0.18
 0.0020
 Signif. decrease
17/L
 0.579
 0.036
 -0.64 ± 0.87
 0.48
 No signif. change
17/R
 0.482
 0.054
 -0.32 ± 0.49
 0.52
 No signif. change
18/L
 0.628
 0.041
 -0.28 ± 0.30
 0.36
 No signif. change
18/R
 0.625
 0.057
 0.43 ± 0.28
 0.13
 No signif. change
19/L
 0.739
 0.143
 -0.44 ± 0.33
 0.19
 No signif. change
19/R
 0.693
 0.076
 -0.30 ± 0.36
 0.41
 No signif. change

Bone et al. Nutrition & Metabolism 2007 4:12   doi:10.1186/1743-7075-4-12